Cargando…
Host-targeted niclosamide inhibits C. difficile virulence and prevents disease in mice without disrupting the gut microbiota
Clostridium difficile is the leading cause of nosocomial diarrhea and colitis in the industrialized world. Disruption of the protective gut microbiota by antibiotics enables colonization by multidrug-resistant C. difficile, which secrete up to three different protein toxins that are responsible for...
Autores principales: | Tam, John, Hamza, Therwa, Ma, Bing, Chen, Kevin, Beilhartz, Greg L., Ravel, Jacques, Feng, Hanping, Melnyk, Roman A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286312/ https://www.ncbi.nlm.nih.gov/pubmed/30531960 http://dx.doi.org/10.1038/s41467-018-07705-w |
Ejemplares similares
-
Pilin Vaccination Stimulates Weak Antibody Responses and Provides No Protection in a C57Bl/6 Murine Model of Acute Clostridium difficile Infection
por: Maldarelli, Grace A, et al.
Publicado: (2016) -
The development of live biotherapeutics against Clostridioides difficile infection towards reconstituting gut microbiota
por: Zhang, Yongrong, et al.
Publicado: (2022) -
Structure of the full-length Clostridium difficile toxin B
por: Chen, Peng, et al.
Publicado: (2019) -
Tauroursodeoxycholic Acid Inhibits Clostridioides difficile Toxin-Induced Apoptosis
por: Pike, Colleen M., et al.
Publicado: (2022) -
Gut microbiota and microbiota-based therapies for Clostridioides difficile infection
por: Chopra, Teena, et al.
Publicado: (2023)